ATEROSKLEROZ VA SURUNKALI YALLIG‘LANISH: PATOGENEZ, KLINIK AHAMIYAT VA PROFILAKTIK YONDASHUVLAR
DOI:
https://doi.org/10.5281/zenodo.20507572Keywords:
atherosclerosis, chronic inflammation, endothelial dysfunction, LDL, macrophage, cytokines, NLRP3 inflammasome, cardiovascular diseases, plaque, hs-CRP.Abstract
This article analyzes the pathogenetic relationship between atherosclerosis and chronic inflammation. Atherosclerosis is a chronic progressive disease characterized by lipid accumulation in the arterial wall, endothelial dysfunction, immune cell activation, and fibrous plaque formation. According to current scientific concepts, atherosclerosis is not only a disorder of lipid metabolism but also a complex immune-metabolic process closely associated with chronic low-grade inflammation. Inflammatory mediators, macrophages, T lymphocytes, cytokines, oxidized LDL, and the NLRP3 inflammasome play an important role in the formation, progression, and destabilization of atherosclerotic plaques. The article discusses major risk factors, inflammatory mechanisms, clinical consequences, and modern approaches to prevention and treatment.References
World Health Organization. Cardiovascular diseases. WHO Fact Sheet, 2025.
Chen P. et al. NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies. Frontiers in Pharmacology, 2024.
Khair M. et al. The role of the NLRP3 inflammasome in atherosclerotic disease: Systematic review and meta-analysis. Journal of Cardiology, 2024.
Ridker P.M. et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine, 2017.
European Society of Cardiology. 2024 ESC Guidelines for the management of chronic coronary syndromes. ESC, 2024.
American College of Cardiology. Low-Dose Colchicine for Atherosclerosis: Key Points. ACC, 2024.
European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology. Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis. ESC, 2025.
Ross R. Atherosclerosis — An Inflammatory Disease. New England Journal of Medicine, 1999.
Libby P. Inflammation in Atherosclerosis. Nature, 2002.
Hansson G.K., Hermansson A. The immune system in atherosclerosis. Nature Immunology, 2011.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Innovative Academy RSC

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite